LumiThera announced today that it closed the second tranche of its Series C financing round with more than $10 million raised. The photobiomodulation (PBM) treatment developer earmarked the proceeds from the funding round for further clinical testing and commercialization of its Valeda light delivery system for treating dry age-related macular degeneration (AMD). LumiThera’s Valeda system […]
Optos Inc.
LumiThera inks distro deal with Nikon’s Optos
LumiThera said today it inked a distribution deal with Nikon (TYO:7731) subsidiary Optos to distribute its Valeda light delivery system intended for use in treating dry age-related macular degeneration. The deal will position Optos as the exclusive distributor of the device in 12 European countries, the Seattle-based company said. The device has already won CE Mark approval in the […]
Nikon’s Optos, Google’s Verily ink deal for machine learning in retinal imaging
Nikon (TYO:7731) subsidiary Optos and Google (NSDQ:GOOG) unit Verily inked a deal this week to develop technologies for machine learning-enabled retinal imaging. The deal calls for the companies will collaborate on improving the screening for diabetic retinopathy and diabetic macular edema, both among the leading causes of blindness worldwide. The program combines Nikon’s leadership in optical engineering and precision […]
How Optos’ retinal scanner saved a physician’s life
A Hattiesburg, Miss.-based doctor says Optos‘ (LON:OPTS) Optomap retinal imaging camera helped him identify a particularly deadly blood vessel blockage before it could trigger a heart attack, according to the Hattiesburg American. During a demonstration of the system, Dr. David Richardson of Hattiesburg Eye Clinic was scanned by the mapping system which captures a panorama […]
J&J deals Cordis for nearly $2B | The week in medtech M&A
Nikon pushes into medtech with $400 mln Optos acquisition
(Reuters) – Nikon, the 98-year-old Japanese company best known for its cameras, has agreed to buy British retinal imaging firm Optos for 259.3 million pounds ($400 million) as it moves into the medical sector.
Nikon has previously said it intended to enter the medical sector to leverage its optical technologies and the Japanese group sees buying Optos as an important step in that long-term growth plan.
Kazuo Ushida, president of Nikon, said the company would expand the medical business further in the future.
NeuroMetrix names new consumer GM | Personnel Moves
Insulet appoints 1st medical director | Personnel Moves
Insulet (NSDQ:PODD) said it named Dr. Howard Zisser, the former clinical director of the Sansum Diabetes Research Institute, as its 1st medical director.
Considered a leader in diabetes research, Zisser will be involved with a variety of clinical research projects and serve as a medical liaison between Insulet and government leaders, the FDA, and healthcare organizations, Bedford, Mass.-based Insulet said.
ArjoHuntleigh taps Covidien executive | Personnel Moves
Illinois healthcare products maker ArjoHuntleigh hired Rick Lytle, a former Covidien (NYSE:COV) executive, as the new president of company operations in the U.S. and Canada.
Smith & Nephew adds Baroness Bottomley to board of directors | Personnel Moves
British orthopedic giant Smith & Nephew (NYSE:SNN) added former Parliament member and conservative politician Baroness Virginia Bottomley of Nettlestone to its board of directors.
Bottomley served in the U.K.’s House of Commons from 1984 to 2005, after which she was raised to "peerage," a term of ranking for British nobility.
